Influencing factors of neurological function recovery after combined intracranial revascularization in patients with moyamoya disease
10.3760/cma.j.cn115682-20210507-01977
- VernacularTitle:烟雾病患者颅内联合血运重建术后神经功能恢复的影响因素分析
- Author:
Yanfang YANG
1
;
Lihua TANG
;
Qian LI
;
Yingpu FENG
Author Information
1. 河南省人民医院脑血管病五病区，郑州 450000
- Keywords:
Moyamoya disease;
Combined revascularization;
Poor prognosis of neurological function;
Influencing factors
- From:
Chinese Journal of Modern Nursing
2022;28(5):663-667
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore influencing factors of neurological function recovery after combined intracranial revascularization in patients with moyamoya disease.Methods:Using the convenient sampling method, a total of 122 patients with moyamoya disease who were admitted to Henan Provincial People's Hospital from January 2018 to January 2019 were selected as the research objects. Patients with Modified Rankin Scale (mRS) score less than 3 points were set as the good neurological prognosis group ( n=86) , and patients with mRS score greater than or equal to 3 points were set as the poor neurological prognosis group ( n=36) . The clinical data of patients were compared between the two groups. Binary Logistic regression analysis was used to explore risk factors for poor prognosis of neurological function in patients with moyamoya disease after combined intracranial revascularization. Results:Binary Logistic regression analysis showed that Glasgow Coma Score (GCS) , frequent transient ischemic attacks before surgery, Suzuki grade greater than or equal to 3, hypertension, and high systolic high blood pressure were independent risk factors for poor prognosis of neurologic function in patients with moyamoya disease after combined intracranial revascularization ( P<0.05) . Conclusions:Influencing factors for poor neurological outcome after combined intracranial revascularization in patients with moyamoya disease include low GCS score, frequent transient ischemic attacks before surgery, high systolic blood pressure, Suzuki grade greater than or equal to 3 and hypertension. Taking targeted measures may reduce risk of poor neurological prognosis in patients with moyamoya disease.
